-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Cerevel Therapeutics Holdings, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
- Cerevel Therapeutics Holdings, Inc. Earnings Per Share, Basic for the quarter ending March 31, 2024 was -0.73 USD/shares, a 8.96% decline year-over-year.
- Cerevel Therapeutics Holdings, Inc. Earnings Per Share, Basic for the twelve months ending March 31, 2024 was -2.73 USD/shares, a 7.91% decline year-over-year.
- Cerevel Therapeutics Holdings, Inc. annual Earnings Per Share, Basic for 2023 was -2.67 USD/shares, a 15.1% decline from 2022.
- Cerevel Therapeutics Holdings, Inc. annual Earnings Per Share, Basic for 2022 was -2.32 USD/shares, a 40.6% decline from 2021.
- Cerevel Therapeutics Holdings, Inc. annual Earnings Per Share, Basic for 2021 was -1.65 USD/shares, a 17.9% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)